Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

Neuron. 2005 Feb 17;45(4):489-96. doi: 10.1016/j.neuron.2005.01.041.

Abstract

The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the striatum. Loss-of-function mutations in the DJ-1 gene cause early-onset familial parkinsonism. To investigate a possible role for DJ-1 in the dopaminergic system, we generated a mouse model bearing a germline disruption of DJ-1. Although DJ-1(-/-) mice had normal numbers of dopaminergic neurons in the substantia nigra, evoked dopamine overflow in the striatum was markedly reduced, primarily as a result of increased reuptake. Nigral neurons lacking DJ-1 were less sensitive to the inhibitory effects of D2 autoreceptor stimulation. Corticostriatal long-term potentiation was normal in medium spiny neurons of DJ-1(-/-) mice, but long-term depression (LTD) was absent. The LTD deficit was reversed by treatment with D2 but not D1 receptor agonists. Furthermore, DJ-1(-/-) mice displayed hypoactivity in the open field. Collectively, our findings suggest an essential role for DJ-1 in dopaminergic physiology and D2 receptor-mediated functions.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Age Factors
  • Animals
  • Behavior, Animal
  • Blotting, Southern / methods
  • Blotting, Western / methods
  • Cell Count
  • Cerebral Cortex / cytology
  • Cerebral Cortex / physiology
  • Disease Models, Animal
  • Dopamine / deficiency*
  • Dopamine Agonists / pharmacology
  • Dopamine Plasma Membrane Transport Proteins
  • Electric Stimulation / methods
  • Electrochemistry / methods
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Germ-Line Mutation
  • Humans
  • Hypokinesia / physiopathology*
  • Immunohistochemistry / methods
  • In Vitro Techniques
  • Intracellular Signaling Peptides and Proteins
  • Membrane Glycoproteins / metabolism
  • Membrane Transport Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nerve Tissue Proteins / metabolism
  • Neurons / physiology
  • Oncogene Proteins / physiology*
  • Parkinsonian Disorders / genetics
  • Parkinsonian Disorders / metabolism*
  • Protein Deglycase DJ-1
  • Quinpirole / pharmacology
  • RNA, Messenger / biosynthesis
  • Radioligand Assay / methods
  • Receptors, Dopamine D2 / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Substantia Nigra / cytology
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Dopamine Agonists
  • Dopamine Plasma Membrane Transport Proteins
  • Intracellular Signaling Peptides and Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Oncogene Proteins
  • RNA, Messenger
  • Receptors, Dopamine D2
  • Quinpirole
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Tyrosine 3-Monooxygenase
  • PARK7 protein, human
  • Protein Deglycase DJ-1
  • Dopamine